BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

OraPharma, Inc. (OPHM) New Study Shows Standard Therapy For Gum Disease is Significantly More Effective When Combined With Local Antibiotics


8/27/2007 10:44:40 AM

WARMINSTER, Pa.--(BUSINESS WIRE)--A new study published today in the Journal of Periodontology shows that a combination of the locally delivered antibiotic ARESTINĀ® (minocycline hydrochloride) Microspheres, 1mg, plus the standard treatment procedure for gum disease is significantly more effective than standard treatment alone in reducing the amount of surrounding tissue and bone that has been destroyed. The combination of ARESTINĀ® plus standard treatment effectively controls periodontal infection and creates a better environment where healing can occur.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES